Liquid nitrogen

PreclinicalSmall molecule

UUniversity Medical Center Groningen

Liquid nitrogen is one of 2 small molecule programs targeting Airway Disease. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Airway DiseaseCompleted

Airway DiseasePreclinical

Completed

Competition

Competitive Landscape

1 competitor in Airway Disease

#DrugCompanyPhaseTrials

Hizentra

CSL Behring

Phase 3

1 2

Liquid nitrogen

UUniversity Medical Center Groningen

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Treatment1 trial

Comparison of Topical 5%Potassium Hydroxide vs Liquid Nitrogen in the Treatment of Plane Warts

Completed·—·Phase 1·NCT05895071·60 enrolled

Airway Disease1 trial

TruFreeze Cryotherapy Central Airway Disease

Completed·UUniversity Medical Center Groningen·N/A·NCT02572557·20 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Liquid nitrogen. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Liquid nitrogen compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Liquid nitrogen. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Medical Center Groningen company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity Medical Center Groningen

Liquid nitrogen

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Treatment1 trial

Airway Disease1 trial

References

Drug Info

Quick Facts

Related News